Additionally, the evidence that CML leukemic cells present HLA-associated immunogenic peptides derived from the BCR::ABL1 was later confirmed by Clark et al. [11]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.